{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:41:39Z","timestamp":1794220899975,"version":"4.8.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neurobiolaging.2022.03.019","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T18:35:09Z","timestamp":1652726109000},"page":"212-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data"],"prefix":"10.1016","volume":"117","author":[{"given":"Federico","family":"Massa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8711-5702","authenticated-orcid":false,"given":"Steffen","family":"Halbgebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-3620","authenticated-orcid":false,"given":"Lorenzo","family":"Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7652-7023","authenticated-orcid":false,"given":"Patrick","family":"Oeckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0319-7374","authenticated-orcid":false,"given":"Nerea","family":"G\u00f3mez de San Jos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6043-9627","authenticated-orcid":false,"given":"Francesco","family":"Lanfranchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Vigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-6069","authenticated-orcid":false,"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chincarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9811-0897","authenticated-orcid":false,"given":"Flavio","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1148\/radiol.10101284","article-title":"White matter damage in Alzheimer disease and its relationship to gray matter atrophy","volume":"258","author":"Agosta","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00259-019-04461-x","article-title":"In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography","volume":"47","author":"Bastin","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0366-y","article-title":"Metabolic correlates of reserve and resilience in MCI due to Alzheimer's disease (AD) Rik Ossenkoppele","volume":"10","author":"Bauckneht","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF01273157","article-title":"Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele","volume":"103","author":"Blennow","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0006","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0008","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0009","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1148\/rg.343135065","article-title":"Brain PET in suspected dementia: patterns of altered FDG metabolism","volume":"34","author":"Brown","year":"2014","journal-title":"RadioGraphics"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920950319","article-title":"Fluid biomarkers for synaptic dysfunction and loss","volume":"15","author":"Camporesi","year":"2020","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0011","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0012","doi-asserted-by":"crossref","unstructured":"Chiasserini, D., Biscetti, L., Eusebi, P., Salvadori, N., Frattini, G., Simoni, S., De Roeck, N., Tambasco, N., Stoops, E., Vanderstichele, H., Engelborghs, S., Mollenhauer, B., Calabresi, P., Parnetti, L., 2017. Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia. doi:10.1186\/s13195-017-0276-4","DOI":"10.1186\/s13195-017-0276-4"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0013","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/mp.2017.108","article-title":"Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia","volume":"23","author":"Chiotis","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S1041610298005110","article-title":"Neurochemical dissection of synaptic pathology in Alzheimer's disease","volume":"10","author":"Davidsson","year":"1998","journal-title":"Int. psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0015","doi-asserted-by":"crossref","DOI":"10.1023\/A:1023832305702","article-title":"Alzheimer's disease as a disconnection syndrome?","author":"Delbeuck","year":"2003","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0016","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","article-title":"A Standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia","volume":"12","author":"Della Rosa","year":"2014","journal-title":"Neuroinformatics"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0017","first-page":"e12005","article-title":"Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. Alzheimer's Dement","volume":"12","author":"Dhiman","year":"2020","journal-title":"Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0018","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/hbm.20718","article-title":"Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty","volume":"30","author":"Eickhoff","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neurobiolaging.2016.03.033","article-title":"Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework","volume":"52","author":"Garibotto","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0021","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-3-1-reviews3002","article-title":"The synucleins","volume":"3","author":"George","year":"2001","journal-title":"Genome Biol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0022","doi-asserted-by":"crossref","unstructured":"Giannakopoulos, P., K\u00f6vari, E., Herrmann, F.R., Hof, P.R., Bouras, C., 2008. Interhemispheric distribution of Alzheimer disease and vascular pathology in brain aging. doi:10.1161\/STROKEAHA.108.530337.","DOI":"10.1161\/STROKEAHA.108.530337"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0023","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cne.20774","article-title":"RC3\/neurogranin is expressed in pyramidal neurons of motor and somatosensory cortex in normal and denervated monkeys","volume":"493","author":"Guada\u00f1o-Ferraz","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-324306","article-title":"Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease","volume":"92","author":"Halbgebauer","year":"2021","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0025","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/emboj.2009.273","article-title":"Long-term potentiation: two pathways meet at neurogranin","volume":"28","author":"Hayashi","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02988444","article-title":"PET studies in dementia","volume":"17","author":"Herholz","year":"2003","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2012.06.003","article-title":"Axonal degeneration in Alzheimer's disease: When signaling abnormalities meet the axonal transport system","author":"Kanaan","year":"2013","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2022.03.019_bib0029","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","article-title":"Automated Talairach atlas labels for functional brain mapping","volume":"10","author":"Lancaster","year":"2000","journal-title":"Hum. Brain Mapping"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid*","volume":"18","author":"Lle\u00f3","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0031","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archneur.1989.00520380046012","article-title":"Predominant left hemisphere metabolic dysfunction in dementia","volume":"46","author":"Loewenstein","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0032","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1113\/JP275107","article-title":"Glucose and lactate as metabolic constraints on presynaptic transmission at an excitatory synapse","volume":"596","author":"Lucas","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0033","doi-asserted-by":"crossref","first-page":"40263","DOI":"10.1038\/srep40263","article-title":"Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease","volume":"7","author":"Majbour","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2020.09.003","article-title":"The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer{\u2019}s disease","author":"Massa","year":"2020","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02988596","article-title":"Cerebral blood flow and metabolic abnormalities in Aizheimer's disease","volume":"15","author":"Matsuda","year":"2001","journal-title":"Rev. Ann. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0036","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET","volume":"16","author":"Mecca","year":"2020","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/alz.041147","article-title":"Relation between alpha-synuclein and core CSF biomarkers in Alzheimer's disease","volume":"16","author":"Monge-Argil\u00e9s","year":"2020","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0038","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00259-017-3790-5","article-title":"18F\u2013FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage","volume":"44","author":"Morbelli","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0039","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0040","article-title":"Focal brain glucose hypometabolism in patients with neuropsychologic deficits after diffuse axonal injury","volume":"28","author":"Nakashima","year":"2007","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0041","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/ene.13728","article-title":"European association of nuclear medicine and european academy of neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus","volume":"25","author":"Nobili","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0042","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1021\/acs.jproteome.9b00824","article-title":"Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer's disease","volume":"19","author":"Oeckl","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0043","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1074\/mcp.M116.059915","article-title":"Alpha-, beta-, and gamma-synuclein quantification in cerebrospinal fluid by multiple reaction monitoring reveals increased concentrations in Alzheimer's and Creutzfeldt-Jakob disease but no alteration in Synucleinopathies","volume":"15","author":"Oeckl","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0044","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2967\/jnumed.116.184309","article-title":"Progressive disintegration of brain networking from normal aging to alzheimer disease: analysis of independent components of 18F-FDG PET data","volume":"58","author":"Pagani","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0046","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"Mild cognitive impairment","volume":"66","author":"Petersen","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0047","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00259-013-2638-x","article-title":"Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints","volume":"41","author":"Picco","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0048","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0049","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X211001216","article-title":"Crossed cerebellar diaschisis on 18F-FDG PET: Frequency across neurodegenerative syndromes and association with 11C-PIB and 18F-Flortaucipir","author":"Provost","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0051","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1523\/JNEUROSCI.10-12-03782.1990","article-title":"Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate","volume":"10","author":"Represa","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0052","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-016-1597-3","article-title":"Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD","volume":"123","author":"Sanfilippo","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0053","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000489847","article-title":"Neurogranin and BACE1 in CSF as potential biomarkers differentiating depression with cognitive deficits from early Alzheimer's disease: a pilot study","volume":"8","author":"Schipke","year":"2018","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0054","doi-asserted-by":"crossref","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","author":"Selkoe","year":"2002","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0055","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0056","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0057","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0058","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0059","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1523\/JNEUROSCI.23-03-00994.2003","article-title":"Dynamics of gray matter loss in Alzheimer's disease","volume":"23","author":"Thompson","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer's disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0061","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0062","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0063","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40520-018-0948-3","article-title":"Association of cerebrospinal fluid Neurogranin with Alzheimer's disease","volume":"31","author":"Wang","year":"2019","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0064","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0065","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1373\/clinchem.2017.283028","article-title":"Neurogranin as cerebrospinal fluid biomarker for alzheimer disease: an assay comparison study","volume":"64","author":"Willemse","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0066","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.03.019_bib0067","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nn.4492","article-title":"[18F]FDG PET signal is driven by astroglial glutamate transport","volume":"20","author":"Zimmer","year":"2017","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:43:55Z","timestamp":1759319035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458022001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":67,"alternative-id":["S0197458022001130"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.03.019","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}